What is Cds?
Cds, operating within the dust mite elimination sector, specializes in providing effective solutions for combating dust mites, a common cause of allergies and skin conditions. The company's flagship product, the ダニ捕りロボ, has garnered considerable user acclaim for its efficacy in household dust mite eradication. Cds primarily targets families, especially those with children affected by atopic dermatitis, aiming to mitigate the health concerns associated with dust mite infestations. The company also offers guidance on optimal purchasing strategies and product comparisons to ensure consumers secure the best value.
How much funding has Cds raised?
Cds has raised a total of $376K across 2 funding rounds:
Debt
$150K
Debt
$226K
Debt (2020): $150K with participation from PPP
Debt (2021): $226K led by PPP
Key Investors in Cds
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Cds?
With a substantial large-scale late-stage funding context, Cds is poised for significant growth and market penetration. The recent strategic investment suggests a focus on scaling operations, enhancing product development, and potentially expanding its market reach. This capital infusion will likely enable Cds to further solidify its position as a leader in dust mite solutions, addressing a critical need for allergy sufferers and health-conscious households.
See full Cds company page
